Your browser doesn't support javascript.
loading
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group.
von Tresckow, Julia; Heyl, Nikola; Robrecht, Sandra; Giza, Adam; Aldaoud, Ali; Schlag, Rudolf; Klausmann, Martine; Linde, Hartmut; Stein, Wolfgang; Schwarzer, Andreas; Fischer, Kirsten; Cramer, Paula; Eichhorst, Barbara; Hallek, Michael; Fink, Anna Maria.
  • von Tresckow J; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Julia.vontresckow@uk-essen.de.
  • Heyl N; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Robrecht S; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Giza A; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Aldaoud A; Praxis für Hämatologie und Onkologie, Leipzig, Germany.
  • Schlag R; Hämatologisch-Onkologische Schwerpunktpraxis, Würzburg, Germany.
  • Klausmann M; Gemeinschaftspraxis, Aschaffenburg, Aschaffenburg, Germany.
  • Linde H; MVZ für Blut und Krebserkrankungen, Potsdam, Germany.
  • Stein W; Klinikum Frankfurt Oder, Frankfurt, Germany.
  • Schwarzer A; Onkopraxis Probstheida, Leipzig, Germany.
  • Fischer K; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Cramer P; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Eichhorst B; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Hallek M; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Fink AM; Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Ann Hematol ; 102(11): 3083-3090, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37358640